The Biggest Virtual Congress on Immunotherapeutics

Speakers

Prof. Oliver Dorigo

Tumor associated Macrophages in Ovarian Cancer

Director, Division Gynecologic Oncology and Director, Stanford Gynecologic Oncology Clinical Care Program Stanford University, Stanford, US

Dr. Kristin G. Anderson

Engineering T cells to overcome immune suppression in the solid tumor microenvironment

Beirne B. Carter Center for Immunology Research, University of Virginia Comprehensive Cancer Center, Charlottesville, VA, USA

Dr Charalampos Papagoras

Inflammatory pathways in the spondyloarthritis spectrum and treatment considerations

Democritus University of Thrace, University Hospital of Alexandroupolis, Greece

Dr. Nour Al Jalbout

Spotting ILD in Autoimmune Disease: The Role of POCUS in Early Detection and Disease Monitoring

Harvard Emergency Ultrasound Fellowship Program and Emergency Medicine at Harvard Medical School, Boston, USA

Prof. Gary Xiao

AI-derived precision diagnosis, focusing on pancreatic cancer

Molecular Pharmacology, School of Chemical Engineering, Dalian University of Technology, Dalian, China

Prof. Sheila K. Singh

Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR-T cells

McMaster Children’s Hospital, Hamilton, ON, Canada

Prof. Panagiotis Skendros

Translational medicine: lessons from autoinflammatory disorders

Democritus University of Thrace, University Hospital of Alexandroupolis, Greece

Dr. Minna Kohler

POCUS in Autoimmune Disease: Early Diagnosis and Tracking Response to Immunotherapy

Director of the Rheumatology Musculoskeletal Ultrasound (MSKUS) Program, Massachusetts General Hospital (MGH), Boston, USA

Dr Konstantinos Tselios

CAR-cell therapies in autoimmunity

Department of Medicine, McMaster University, Hamilton, ON, Canada

Dr Sasha Stanton

Developing immune therapies for prevention in breast cancer

Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA

Prof. Jianyu Rao

SMART Diagnostics in the Precision Care of Cancer

Department of Pathology and Lab Med, David Geffen School of Medicine, University of California, Los Angeles, USA

Prof. Delia Goletti

Cysteamine as a host-directed therapy for infectious diseases

National Institute for Infectious Diseases-IRCCS L. Spallanzani, Rome, Italy

Prof. George Hajishengallis

Clonal hematopoiesis and chronic disease

University of Pennsylvania, Penn Dental Medicine Department of Translational Sciences, PA, USA

Prof. Antonio Facchiano

Updates in melanoma diagnostics

Istituto Dermopatico dell’Immacolata, IDI-IRCCS, Rome, Italy

Prof. Hamid Shokoohi

AI-Power Up: POCUS Devices and Clinical Application

Harvard Medical School, Department of Emergency Medicine, Massachusetts General Hospital, Harvard, USA

Dr Andrew L. Coveler

Immunotherapy in GI Cancers: Recent Developments

Fred Hutchinson Cancer Center, University of Washington Division of Hematology and Oncology, Seattle, WA, USA

Prof. Peter Lin

PD-L1+ aneuploid circulating tumor endothelial cells (CTECs) detected by SE-iFISH in patients with NSCLC or melanoma exhibit resistance to ICI immunotherapy

Cytelligen, San Diego, CA, USA

Jeffery Kimbrough

Multiple, consecutive quality checkpoints significantly improve the value of the bio-banked material for research

Head of Strategic Partnerships, Genomics Subject Matter Expert, Reference Medicine, USA